非编码DNA在癌症生物学中也占一席之地

doi:10.1038/nature13602
Putativecis-regulatorydriversincolorectalcancer
HalitOngen1,2,3,ClausL.Andersen4,JesperB.Bramsen4,BodilOster4,MadsH.Rasmussen4,PedroG.Ferreira1,2,3,JuanSandoval5,EnriqueVidal5,NicolaWhiffin6,AlexandraPlanchon1,2,3,IsmaelPadioleau1,2,3,DeborahBielser1,2,3,LucianaRomano1,2,3,IanTomlinson7,RichardS.Houlston6,ManelEsteller5,8,9,TorbenF.Orntoft4&EmmanouilT.Dermitzakis1,2,3
Thecis-regulatoryeffectsresponsibleforcancerdevelopmenthavenotbeenasextensivelystudiedastheperturbationsoftheproteincodinggenomeintumorigenesis1,2.Tobettercharacterizecolorectalcancer(CRC)developmentweconductedanRNA-sequencingexperi-mentof103matchedtumourandnormalcolonmucosasamplesfromDanishCRCpatients,90ofwhichweregermline-genotyped.Byinvestigatingallele-specificexpression(ASE)weshowthatthegermlinegenotypesremainimportantdeterminantsofallelicgeneexpressionintumours.UsingthechangesinASEinmatchedpairsofsampleswediscover71geneswithexcessofsomaticcis-regulatoryeffectsinCRC,suggestingacancerdriverrole.Wecorrelategeno-typesandgeneexpressiontoidentifyexpressionquantitativetraitloci(eQTLs)andfind1,693and948eQTLsinnormalsamplesandtumours,respectively.Weestimatethat36%ofthetumoureQTLsareexclusivetoCRCandshowthatthisspecificityispartiallydrivenbyincreasedexpressionofspecifictranscriptionfactorsandchangesinmethylationpatterns.Weshowthattumour-specificeQTLsaremoreenrichedforlowCRCgenome-wideassociationstudy(GWAS)PvaluesthansharedeQTLs,whichsuggeststhatsomeoftheGWASvariantsaretumourspecificregulatoryvariants.Importantly,tumour-specificeQTLgenesalsoaccumulatemoresomaticmutationswhencomparedtothesharedeQTLgenes,raisingthepossibilitythattheyconstitutegermline-derivedcancerregulatorydrivers.Collectivelytheintegrationofgenomeandthetranscriptomerevealsasubstan-tialnumberofputativesomaticandgermlinecis-regulatorycancerchangesthatmayhavearoleintumorigenesis.
Thenon-codinggenomehassofarbeenoverlookedinthesearchfordriversincancer,exceptforsomeisolatedexamples1,2.Thegenomecontainsregulatorynon-codinggermlinevariationaffectinggeneexpres-sion,namelyeQTLs,whicharemajorcomponentsincomplexdiseasepredisposition3,andthesehavenotbeenexaminedwithinthecontextoftumorigenesis.EpistasisbetweeneQTLsandcodingmutationsingeneshasaroleindisease4;thereforeitislikelythatinteractionsbetweensomaticregulatoryvariantsoreQTLsandcodingvariationareimport-antintumorigenesis.ToexaminethisweperformedanRNAsequen-cinganalysisof103matchedtumourandnormalcolonmucosaCRCsamples(SupplementaryFig.2)oftheSYSCOLconsortium(Supplemen-taryTable1).Ninetysamplesweregenotypedfortheirgermlinegenomeandimputedto1000Genomesphase1release5(SupplementaryMethods).WealsoRNA-sequenced20referencetissuestocreateamorecompre-hensivecontroltranscriptomeforCRC.AgeneraloverviewandmainfindingsaresummarizedinSupplementaryFig.3.
Weexaminedtranscriptomeperturbationsduringtumorigenesisbyidentifyingdifferentiallyexpressedgenes(DEGs)andfind1,676DEGs(falsediscoveryrate(FDR)55%,foldchange$2)(SupplementaryTable2andSupplementaryFig.4).ThefunctionaltermsenrichedinDEGsaregiveninSupplementaryTable3,andpathwaysimpacted,whichincludeknownCRCpathways,aregiveninSupplementaryTable4.There
1
isnosignificantdifferenceofdifferentialexpressionbetweenknownCRCdrivergenes6,7orTheCancerGenomeAtlas(TCGA)pan-cancergenes7,8,andexpressionmatchedrandomgenes(SupplementaryFig.5).Inaddition,wefind213differentiallysplicedgenes(FDR55%)(Sup-plementaryTable5,SupplementaryFigs6and7).AmongtheseareTGFBI(ref.9),RASA1(ref.10),SLC26A3(ref.11)andSLC39A14(ref.12),whichhavebeenpreviouslyimplicatedinCRC.Theenrichedfunc-tionaltermsaregiveninSupplementaryTable6.
Wetestedtherelationshipofsamples’geneexpressionandsearchedforregionsofthegenomeinwhichCRCmodifiesthecorrelationofpro-ximalgeneexpression.Weobservethatthetumoursamples,normalsamples,andthe20referencetissuesamplesformthreedistinctclus-ters(SupplementaryFig.8),andthevarianceoftheCRCtranscriptomeisincreasedwhencomparedtothenormalsamples(SupplementaryFig.9).InallchromosomesthereareblocksofproximalgeneswhosecorrelationsarealteredinCRC(SupplementaryFigs10and11,andSup-plementaryTable7)pointingtocoordinatedregulationlikelyduetoconsistentepigeneticeffectsandlocuscontrolregions.TheresultsabovesuggestarewiringoftheregulatorynetworksinCRC.
Tofurtherdissectcis-regulatoryeffectsinCRCweexaminedvariationinregulationofgeneexpression.Onepowerfulmethodfordiscoveringcis-regulatoryvariabilityisASEanalysis,whichwasconductedasdescribedpreviously13.Wefindthatapproximately10%ofcodingheterozygoussitesexhibitsignificantASE(FDR51%,P,0.001).TheproportionofsiteswithASEissignificantlyhigherintumourscomparedtonormalsamples(Fig.1a)andapproximately34%ofASEisCRC-specific.Thisexcessislikelytobeanindicationofcopynumberalterations(CNAs)thathavebeendescribedpreviously6,14,15.Furthermore,inapproximately10%ofASEsitessignificantinbothmatchedsamples,thedirectionoftheASEeffectisreversed(Fig.1b),alsoindicatinggenesfoundinpotentialCNAregionsorgeneswherethecis-regulatorylandscapehasbeenaltered.
Weproposethatthesomaticeventsintheregulatoryregionsofgenesarereflectedinthedifferenceofallelicratiosbetweenmatchedpairsatexpressedheterozygoussites.WedefineASEsomaticevents(Supplemen-taryMethods)andobserveasignificantcorrelation(Spearman’srho50.05,P58.831027)betweenASEsomaticeventratesandcodingsomaticmutationrates16ofgenes,indicatingthatsomaticASEeventsmaybemorelikelytobeselectedingenesimplicatedinCRC(Fig.2aandSupplementaryFig.12).Todetermineascoreofsomaticdysregu-lationwecomparedtheASEsomaticeventrateofeachgenetoallothergenes(SupplementaryMethods).Thescoreisdefinedastheenrich-mentoflowPvalues(p1)17.Weobserveabimodaldistributionofp1valueswheremostgenesaresimilartoothergenesbutasmallfractionofgenesdemonstratehighp1,representinggeneswithdysregulation(SupplementaryFig.13andSupplementaryTable8).KnownCRCdrivergenes6,7andTCGApan-cancergenes7,8havesignificantlyhigherp1comparedtoothergenes(SupplementaryFig.14).Therefore,thep1
DepartmentofGeneticMedicineandDevelopment,UniversityofGenevaMedicalSchool,1211Geneva,Switzerland.2InstituteforGeneticsandGenomicsinGeneva(iGE3),UniversityofGeneva,1211Geneva,Switzerland.3SwissInstituteofBioinformatics,1211Geneva,Switzerland.4DepartmentofMolecularMedicine,AarhusUniversityHospital,8000Aarhus,Denmark.5CancerEpigeneticsandBiologyProgram(PEBC),BellvitgeBiomedicalResearchInstitute(IDIBELL),08908Barcelona,Catalonia,Spain.6DivisionofGeneticsandEpidemiology,TheInstituteofCancerResearch,Sutton,SurreySM25NG,UK.7NuffieldDepartmentofClinicalMedicineandOxfordNIHRComprehensiveBiomedicalResearchCentre,WellcomeTrustCentreforHumanGenetics,RooseveltDrive,OxfordOX37BN,UK.8
´CatalanadeRecercaiEstudisAvançats(ICREA),08010Barcelona,DepartmentofPhysiologicalSciencesII,SchoolofMedicine,UniversityofBarcelona,08007Barcelona,Barcelona,Spain.9Institucio
Spain.
00MONTH2014|VOL000|NATURE|1
©2014Macmillan Publishers Limited. All rights reserved
Relationship between Expression of CEA, E-cadherin and Liver Metastasis in Colorectal Cancer_专业资料。CiJl cl20):2~3 hn iOno(0854942CnDoI010/1850802— ...
Long-term colorectal-cancer incidence and mortality after lower endoscopy. ...Moreover, there is little evidence to suggest that the putative mechanisms ...
In colorectal cancer cells, it potently suppressed anchorage-independent growth by inhibiting COX-1 activity. 6CEPN also effectively suppressed tumor growth in...
Epigenetic changes in colorectal cancer_生物学_自然科学_专业资料。Epigenetic changes in colorectal cancer Yan Jia’, a Epigenetic changes in colorectal ...
Wild-type KRAS is required forpanitunumab efficacy in patients with metastatic colorectal cancer._临床医学_医药卫生_专业资料。VOLUME 26 ? NUMBER 10 ? ...
ANTICANCER RESEARCH 29: 3369-3374 (2009) A Novel K-ras Mutation in Colorectal Cancer. A Case Report and Literature Review RAFFAELE PALMIROTTA1, ...
in colorectal cancer coincide_生物学_自然科学_专业...elements within putative enhancers with sites for ...cis-regulatory elements required for macrophage and...
Liver angiogenesis: tumor host interaction in non-metastatic colorectal cancer 隐藏>> Lv giieran0geneSS:um os nertoni itorhtitaci nnon-etsatccorcaIanc mati o...
regulatory noncoding RNAs, have an altered expression in colorectal cancer. ...with a higher expression of miR-143, which is a putative tumor suppressor...
c codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated ? 2008 by ...
热门文档